|
Sign In to gain access to subscriptions and/or personal tools.
|
Cardiac Damage in Rodents after Exposure to Bis(2-chloroethoxy)methane
June K. Dunnick
Environmental Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA, dunnickj@niehs. nih.gov
Warren Lieuallen
Pathology Associates (PAI) Division of Charles River Laboratories, Durham, North Carolina, USA
Carolyn Moyer
Pathology Associates (PAI) Division of Charles River Laboratories, Durham, North Carolina, USA
Denise Orzech
Environmental Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA
Abraham Nyska
Laboratory of Experimental Pathology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA
We report that an environmental agent, bis(2-chloroethoxy)methane (CEM), caused cardiac toxicity in male and female F344 rats and B6C3F1 mice exposed to the chemical by dermal administration at doses of 0, 50, 100, 200, 400 or 600 mg/kg 5 days a week for up to 14 weeks. Treatment-related deaths occurred in 10/10 male and 10/10 female rats at 600 mg/kg, in 2/10 female rats at 400 mg/kg, and in 3/10 female mice at 600 mg/kg. The heart lesions were more severe in rats than mice, and more severe in females than males. In rats, the no-observed-adverse-effect level (NOAEL) for the heart lesions was 200 mg/kg for males and 100 mg/kg for females; in mice, it was more than 600 mg/kg for males and 200 mg/kg for females. Multifocal, widespread vacuolization of the myocytes comprised the main morphological feature of the lesions, and only in rats was it accompanied by mononuclear cell infiltration, myocytic necrosis and atrial thrombosis. Hearts from male rats were immunohistochemically stained for troponin T (cTnT) protein. Loss of cytoplasmic cTnT correlated with histopathological damage only in the 600 mg/kg animals. CEM is metabolized to thiodiglycolic acid, a chemical that causes mitochondrial dysfunction. It is hypothesized that mitochondrial damage leads to the heart toxicity from bis(2-chloroethoxy)methane.
Key Words: Bis(2-chloroethoxy)methane cardiotoxictiy myocyte vacuolization mitochondrial dysfunction troponin T rat mouse.
References
- Antman, E.M. (2002). Decision making with cardiac troponin tests [editorial]. N Engl J Med 346, 2079—82.[Free Full Text]
- Apple, F.S. (2001). Cardiac Troponin Assays: Analytical issues and clinical reference range cutpoints. Cardiovasc Toxicol 1, 93—8.[CrossRef][Medline]
[Order article via Infotrieve]
- Bernat, A., and Herbert, J.M. (1994). Effect of various drugs on adriamycin-enhanced venous thrombosis in the rat: Importance of PAF. Thromb Res 75, 91—7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bleuel, H., Deschl, U., Bertsch, T., Bolz, G., and Rebel, W. (1995). Diagnostic efficiency of troponin T measurements in rats with experimental myocardial cell damage. Exp Toxicol Pathol 47, 121—7.[Web of Science][Medline]
[Order article via Infotrieve]
- Childs, A.C., Phaneuf, S.L., Dirks, A.J., Phillips, T., and Leeuwenburgh, C. (2002). Doxorubicin treatment in vivo causes cytochrome c release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res 62, 4592— 8.[Abstract/Free Full Text]
- Dunn, O.J. (1964). Multiple comparisons using rank sums. Technometrics 6, 241—52.[CrossRef]
- Dunnett, W. (1955). A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50, 1095—121.
- Environmental Protection Agency (2003). High Production Volume Chemical List.
http://www.epa.gov/chemrtk/hpvchmlt.htm . - Fujihira, S., Yamamoto, T., Matsumoto, M., Yoshizawa, K., Oishi, Y., Fugii, T., Noguchi, H., and Mori, H. (1993). The high incidence of atrial thrombosis in mice given doxorubicin. Toxicol Pathol 21, 362—8.[Web of Science][Medline]
[Order article via Infotrieve]
- Green, T., and Hathway, D.E. (1975). The biological fate in rats of vinyl chloride in relation to its oncogenicity. Chem Biol Interact 11, 545—62.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Grossblatt, N. (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.
- Hazardous Substance Database (2002). Hazardous Substances Databases, National Institute of Occupational Safety and Health, Washington, DC.
http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB . - Herman, E.H., El-Hage, A.N., Ferrans, V.J., and Ardalan, B. (1985). Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats. Toxicol Appl Pharmacol 78, 202—14.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Herman, E.H., Lipshultz, S.E., Rifai, N., Zhang, J., Papoian, T., Yu, Z.X., Takeda, K., and Ferrans, V.J. (1998). Use of cardiac troponin T levels as an indicator of doxorubinin-induced cardiotoxicity. Cancer Res 58, 195—7.[Abstract/Free Full Text]
- Herman, E.H., Zhang, J., Chadwick, D.P., and Ferrans, V.J. (1996). Age dependence of the cardiac lesiosn induced by minoxidil in the rat. Toxicology 110, 71—83.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Herman, E.H., Zhang, J., Chadwick, D.P., and Ferrans, V.J. (2000). Comparison of the protective effects of amifostine and dexrazoxane against the toxicty of doxorubicin in spontaneously hypertensive rats. Cancer Chemother Pharmacol 45, 329—34.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Herman, E.H., Zhang, J., Lipshultz, S.E., Rifai, N., Chadwick, D.P., Takeda, K., Yu, Z.X., and Ferrans, V.J. (1999). Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J Clin Oncol 17, 2237—43.[Abstract/Free Full Text]
- Hopkins, P.N., and Williams, R.R. (1981). A survey of 246 suggested coronary risk factors. Atherosclerosis 40, 1—52.[Medline]
[Order article via Infotrieve]
- Hsu, S., and Raine, L. (1981). Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 29, 1349—53.[Abstract]
- Jin, J.P., Huang, Q.A., Yeh, H.I., and Lin, J.J.C. (1992). Complete nucleotide sequence and structural organization of rat cardiac troponin T gene. J Mol Biol 227, 1269—76.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Jones, B.K., and Hathway, D.E. (1978). Differences in metabolism of vinylidene chloride between mice and rats. Br J Cancer 37, 411—7.[Web of Science][Medline]
[Order article via Infotrieve]
- Katus, H.A., Looser, S., Hallermayer, K., Remppis, A., Scheffold, T., Borgya, A., Essig, U., and Geuss, U. (1992). Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clinic Chem 38, 383—93.
- Katus, H.A., Remppis, A., Neumann, F.J., Scheffold, T., Diederich, K.W., Vinar, G., Noe, A., Matern, G., and Kuebler, W. (1991). Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 83, 902—12.[Abstract/Free Full Text]
- Kragten, J.A. (1996). Cardiac troponin T release into plasma after acute myocardial infarction: Only fractional recovery compared with enzymes. Ann Clin Biochem 33, 314—23.[Web of Science][Medline]
[Order article via Infotrieve]
- Lesnefsky, E.J., Moghaddas, S., Tandler, B., Kerner, J., and Hoppel, C.L. (2001). Mitochondrial dysfunction in cardiac disease: Ischemia-reperfusion, aging, and heart failure. J Mol Cell Cardiol 33, 1065—89.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Marin-Garcia, J., and Goldenthal, M.J. (2002). Understanding the impact of mitochondrial defects in cardiovascular disease: A review. J Card Failure 8, 347—60.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mathews, J.M., and Jeffcoat, A.R. (2002). Bis(2-chloroethoxy)methane: Comparative metabolism and excretion in rats and mice. NIEHS Contract No. N01-ES-75407 contract with RTI, Research Triangle Park, NC RTI Report No. RTI/64U-6855/14P, Feb 28, 2002.
- Mesnard, L., Samson, F., Espinasse, I., Durand, J., Neveux, J., and Mercadier, J. (1993). Molecular cloning and development expression of human cardiac troponin T. Fed Eur Biochem Soc 328, 139—44.
- National Toxicology Program (1992). Toxicology and Carcinogenesis Studies of Monochloroacetic Acid in F344/N rats and B6C3F1 mice. Research Triangle Park, NC.
- National Toxicology Program (2000). Bulk chemical limited analysis report, bis(2-chloroethoxy)methane. NIH Contract No. N01-ES-55397, Task CHEM04776.
- National Toxicology Program (2002). 90-day toxicity studies of bis(2-chloroethoxy)methane. Battelle Columbus reports submitted to NTP-G004164-AD & G004164-AE, July and October 2002.
- O'Brien, P.J., Dameron, G.W., Beck, M.L., Kang, Y.J., Erickson, B.K., Di Battista, T.H., Miller, K.E., Jackson, K.N., and Mittelstadt, S. (1997). Cardiac troponin T is a sensitive, specific, biomarker of cardiac injury in laboratory animals. Lab Anim Sci 47, 486—95.[Web of Science][Medline]
[Order article via Infotrieve]
- Ohman, E.M., Armstrong, P.W., Christenson, R.H., Granger, C.B., Katus, H.A., Hamm, C.W., O'Hanesian, M.A., Wagner, G.S., Kleiman, N.S., Harrell, F.E., Jr., Califf, R.M., Topol, E.J., and Gusto-Ila Investigators. (1996 ). Cardiac troponin T levels for risk stratification in acute myocardial ischemia. NEJM 335, 1333—41.[Abstract/Free Full Text]
- Pearlstone, J.R., Carpenter, M.R., and Smillie, L.B. (1986). Amino acid sequences of rabbit cardiac troponin T. J Biol Chem 261, 16795—810.[Abstract/Free Full Text]
- Raggi, A., Grand, R.J.A., Moir, A.J.G., and Perry, S.V. (1989). Structure-function relationships in cardiac troponin T. Biochim Biophys Acta 997, 135—43.[CrossRef][Medline]
[Order article via Infotrieve]
- Ruben, Z., Arceo, R.J., Bishop, S.P., Elwell, M.R., Kerns, W.D., Mesfin, G.M., Sandusky, G.E., and Van Vleet, J.F. (2000). Non-proliferative lesions of the heart and vasculature in rats. CV-1. Guides for Toxicologic Pathology, pp. 1—10. STP/ARP/AFIP.
- Shirley, E. (1977). A non-parametric equivalent of William's test for contrasting increasing dose levels of a treatment. Biometrics 33, 386—9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sorescu, D., and Griendling, K.K. (2002). Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail 8, 132—40.[Medline]
[Order article via Infotrieve]
- The Joint European Society of Cardiology/American College of Cardiology Committee (2000). Myocardial infaction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infaction. Europ Heart J 21, 1502—13.[Abstract/Free Full Text]
- van Loo, G., Saelens, X., van Gurp, M., MacFarlane, M., Martin, S.J., and Vandenabelle, P. (2002). The role of mitochondrial factors in apoptosis: A Russian roulette with more than one bullet. Cell Death Differ 9, 1031—42.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Visarius, T.M., Bahler, H., Kupfer, M.A., Cerny, T., and Lauterburg, B.H. (1998). Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in rats. Drug Metab Disp 26, 193—6.[Abstract/Free Full Text]
- Wang, X. (2001). The expanding role of mitochondria in apoptosis. Genes Dev 15, 2922—2933.[Free Full Text]
- Yllner, S. (1971). Metabolism of chloracetate-1-14C in the mouse. Acta Pharmacol Toxicol 30, 69—80.[Medline]
[Order article via Infotrieve]
- Yussman, M.G., Toyokawa, T., Odley, A., Lynch, R.A., Wu, G., Colbert, M.C., Aronow, B.J., Lorenz, J.N., and Dorn, G.W.I. (2002). Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat Med 8, 725—30.[Web of Science][Medline]
[Order article via Infotrieve]
Toxicologic Pathology, Vol. 32, No. 3,
309-317 (2004)
DOI: 10.1080/01926230490431501

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|